At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Apr 14, 2026 at 20:00 ET
Three United Therapeutics executives, including the CEO, CFO, and General Counsel, conducted open-market share sales totaling $459K over a 7-day period, following large non-cash derivative exercises. The sales represent less than 0.002% of the company's $25.4B market cap and appear to be part of pre-planned transactions following stock option exercises.
- CEO Martine Rothblatt sold $227K worth of shares (395 shares) across multiple days in the cluster window at prices between $569.78 and $575.29.
- CFO James Edgemond sold $298K worth of shares (520 shares) on April 16, following the exercise of 20,000 derivative securities at two different strike prices.
- EVP Paul Mahon sold $115K worth of shares (200 shares) on April 16, following the exercise of 16,600 derivative securities.
- Total open-market sales in the cluster: $459K, representing less than 0.002% of $25.4B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access